| Literature DB >> 32173913 |
Giuseppe Schiavone1, Florian Fallegger1, Xiaoyang Kang1, Beatrice Barra2, Nicolas Vachicouras1, Evgenia Roussinova1, Ivan Furfaro1, Sébastien Jiguet1, Ismael Seáñez3, Simon Borgognon2,3, Andreas Rowald3, Qin Li4,5, Chuan Qin4, Erwan Bézard4,5,6,7, Jocelyne Bloch3,8, Grégoire Courtine3,8, Marco Capogrosso2, Stéphanie P Lacour1.
Abstract
The convergence of materials science, electronics, and biology, namely bioelectronic interfaces, leads novel and precise communication with biological tissue, particularly with the nervous system. However, the translation of lab-based innovation toward clinical use calls for further advances in materials, manufacturing and characterization paradigms, and design rules. Herein, a translational framework engineered to accelerate the deployment of microfabricated interfaces for translational research is proposed and applied to the soft neurotechnology called electronic dura mater, e-dura. Anatomy, implant function, and surgical procedure guide the system design. A high-yield, silicone-on-silicon wafer process is developed to ensure reproducible characteristics of the electrodes. A biomimetic multimodal platform that replicates surgical insertion in an anatomy-based model applies physiological movement, emulates therapeutic use of the electrodes, and enables advanced validation and rapid optimization in vitro of the implants. Functionality of scaled e-dura is confirmed in nonhuman primates, where epidural neuromodulation of the spinal cord activates selective groups of muscles in the upper limbs with unmet precision. Performance stability is controlled over 6 weeks in vivo. The synergistic steps of design, fabrication, and biomimetic in vitro validation and in vivo evaluation in translational animal models are of general applicability and answer needs in multiple bioelectronic designs and medical technologies.Entities:
Keywords: biomimetic materials; multimodal characterization; neural implants; soft electrodes
Mesh:
Substances:
Year: 2020 PMID: 32173913 DOI: 10.1002/adma.201906512
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849